โ Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
โน๏ธ Info
๐งพ At a Glance ๐ Core Facts ๐๏ธ Products/Services โญ Ratings ๐งโ๐ผ Executives ๐ฌ My Comments๐ก Analytics
๐ Insights ๐ข Company Q&A (465) ๐ ๏ธ Industry Q&A (98) ๐ Competitors ๐ Price Low ๐ Price Swings โก SWOT ๐๏ธ PEST ๐ Porter's Five Forces โจ Score Positive โ ๏ธ Risk Assessment ๐งฉ Segmentation ๐ ถ Google Links๐ Ratios
๐ฐ Margins ๐ Financial Ratios ๐ฑ Growth ๐ Enterprise Value ๐ Key Metrics ๐ต Dividends๐ง Tools
โ Due Diligence๐ข Press Releases
Date | Press release |
---|---|
2025-05-27 16:05:00 | Global Partners Mourns The Loss Of Board Chairman Richard Slifka Waltham, mass.--(business wire)--global partners lp (nyse: glp) announces with deep sadness the passing of richard slifka, chairman of the board of directors of the partnershipโs general partner, global gp llc. mr. slifka passed away on may 25, 2025, at the age of 85. a steady and thoughtful presence, richard helped shape global over more than six decades, growing the foundation of the business alongside his brother, the late alfred a. slifka, and serving as a consistent voice of integrity and. |
2025-05-22 08:16:00 | Northstrive Biosciences Announces Completion Of Phase I Strategic Review For El-22 Targeting Muscle Loss Associated With Glp-1 Weight Loss Drugs And Age-related Sarcopenia Northstrive biosciences announces completion of phase i strategic review for el-22 targeting muscle loss associated with glp-1 weight loss drugs and age-re |
2025-05-22 02:00:00 | Chequp And Weightwatchers Announce Strategic Partnership To Support Growing Use Of Glp-1 Medications In The Uk Partnership provides chequp members access to weightwatchersโ proven glp-1 companion programme to aid in achieving superior and sustainable results partnership provides chequp members access to weightwatchersโ proven glp-1 companion programme to aid in achieving superior and sustainable results |
2025-05-17 07:15:00 | Fractyl Health Unveils New Rejuvaยฎ Smart Glp-1โข Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency And Safety With Limited Systemic Glp-1 Exposure At Asgct 2025 Data suggests that single dose of rjva-001 leads to durable metabolic improvements with low systemic glp-1 exposure in db/db mouse model of t2dโ potentially simultaneously addressing durability, adherence, and tolerability challenges seen with current glp-1 drugs |
2025-05-13 16:05:00 | Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update - announced preclinical data demonstrating the bioequivalence of rt-114, a bispecific glp-1/glp-2 receptor agonist (pg-102), delivered orally via the ranipillยฎ capsule, to subcutaneous administration of pg-102 - |
2025-05-08 09:20:00 |
|
2025-05-07 08:30:00 |
|
2025-05-07 07:57:00 |
|
2025-05-05 08:00:00 |
|
2025-04-28 16:30:00 |
|
2025-04-25 08:30:00 |
|
2025-04-24 08:30:00 |
|
2025-04-23 09:10:00 |
|
2025-04-22 19:30:00 |
|
2025-04-22 08:31:00 |
|

๐ฐ Browse additional press releases for Global Partners!
Sign up for free or log in๐ Join us and grab your copy of "The Checklist Value Investor โ A Smarter Way to Pick Stocks"